Judge: Investors Didn’t Show Pharmaceutical Company’s Projections Are False
NEWARK, N.J. — A federal judge in New Jersey dismissed without prejudice a putative class complaint brought by investors who said a biopharmaceutical company and certain of its executives misled investors...To view the full article, register now.
Already a subscriber? Click here to view full article